{
  "id": "chromatin-immunoprecipitation",
  "title": "Chromatin immunoprecipitation",
  "lang": "en",
  "source_lang": "en",
  "summary": "Chromatin immunoprecipitation identifies genomic regions associated with selected proteins or histone modifications by antibody-based enrichment of chromatin fragments.",
  "category": "science",
  "subcategory": "biology",
  "type": "concept",
  "aliases": [
    "ChIP",
    "chromatin immunoprecipitation assay"
  ],
  "generated_at": "2026-11-05",
  "model": "pro/gpt-6.1-sol",
  "url": "https://aiwiki.page/en/chromatin-immunoprecipitation/",
  "translations": {
    "zh-Hans": {
      "url": "https://aiwiki.page/zh/chromatin-immunoprecipitation/",
      "json": "https://aiwiki.page/zh/chromatin-immunoprecipitation.json"
    }
  },
  "sections": [
    {
      "heading": "",
      "text": "Chromatin immunoprecipitation (ChIP) is an experimental method for identifying regions of DNA associated with a particular protein or protein modification in cells. It uses an antibody to enrich fragments of chromatin carrying the selected target, followed by analysis of the accompanying DNA. The target may be a sequence-specific transcription factor, a component of the transcriptional machinery, a structural chromosomal protein, or a chemically modified histone. ChIP therefore connects the molecular composition of chromatin with particular positions in a genome.\n\nThe method has become central to studies of gene expression, chromosome organization, and epigenetics. Its principal readouts range from measurements at a few selected loci to genome-wide maps obtained by DNA sequencing. These maps reveal where a target is preferentially recovered, but they do not by themselves establish direct protein–DNA contact, the fraction of cells occupied at a site, or the functional consequences of an interaction. Interpretation depends on the chemistry of chromatin preparation, antibody specificity, experimental controls, and computational analysis."
    },
    {
      "heading": "Historical development and the transition to genome-wide mapping",
      "text": "ChIP emerged from efforts to determine how proteins associate with chromosomes inside cells rather than only with purified DNA in a test tube. Classical biochemical assays could identify DNA sequences recognized by a protein, but cellular chromatin introduces additional constraints: DNA is wrapped around histones, regulatory proteins interact with one another, and accessibility changes with cellular state. Preserving these relationships during extraction was therefore a major experimental challenge.\n\nAn important precursor was the work of Gilmour and Lis in 1984, which used ultraviolet crosslinking and immunoprecipitation to examine protein–DNA associations in Drosophila cells. Their subsequent work mapped RNA polymerase II on transcribed genes. In 1988, Solomon, Larsen, and Varshavsky described formaldehyde crosslinking for mapping protein–DNA interactions in vivo. Formaldehyde became especially influential because it could stabilize chromatin associations in intact cells and its crosslinks could subsequently be reversed, permitting recovery of DNA for analysis.\n\nEarly experiments detected specific recovered sequences using hybridization or polymerase chain reaction. These approaches made ChIP suitable for testing focused hypotheses, such as whether a regulatory protein associated with a particular promoter. Quantitative PCR later improved the reproducibility and dynamic range of locus-specific measurements. Native chromatin immunoprecipitation, conducted without chemical fixation, developed alongside crosslinked approaches and proved particularly useful for studying stable histone–DNA associations and histone modifications.\n\nThe combination of ChIP with DNA microarrays produced ChIP-chip, allowing many genomic regions to be examined simultaneously. In 2000, Ren and colleagues used genome-wide location analysis to map transcription-factor binding in budding yeast. Such work helped establish that regulatory proteins could be studied as components of genome-wide networks rather than only one promoter at a time. Array design nevertheless constrained which regions could be measured, and hybridization introduced sequence-dependent limitations.\n\nIn 2007, several studies established ChIP-seq, combining chromatin immunoprecipitation with massively parallel sequencing. Johnson and colleagues mapped the transcription factor NRSF, also called REST, while Barski and colleagues profiled numerous histone methylations in human T cells. Sequencing greatly expanded genomic coverage and effective resolution, although repetitive DNA remained difficult to map uniquely. Large collaborative projects subsequently adopted ChIP-seq to build reference maps of regulatory proteins and chromatin modifications. This transition shifted much of the methodological emphasis from detecting an individual interaction to comparing large, complex enrichment landscapes across experiments."
    },
    {
      "heading": "Molecular basis and the meaning of enrichment",
      "text": "In eukaryotic cells, the fundamental repeating unit of chromatin is the nucleosome, in which approximately 147 base pairs of DNA wrap around a histone octamer. Histone tails and other exposed surfaces carry chemical modifications, while numerous additional proteins associate with nucleosomes, linker DNA, and regulatory sequences. ChIP exploits these physical associations: if an antibody captures the selected protein or modification, DNA that remains attached to the captured material can be recovered and identified.\n\nThe assay measures enrichment rather than direct observation of an individual binding event. A DNA fragment is more abundant in the immunoprecipitated material when it has a greater probability of being recovered with the target under the experimental conditions. That probability depends on biological occupancy, but also on crosslinking efficiency, fragment production, antibody accessibility, binding affinity, washing conditions, and DNA recovery. Consequently, a twofold difference in ChIP signal does not necessarily mean a twofold difference in the proportion of cells carrying the interaction.\n\nCrosslinked ChIP can recover both direct and indirect associations. A transcription factor may contact DNA itself, or it may be tethered through another protein that contacts DNA. Formaldehyde can preserve protein–protein as well as protein–DNA interactions, so either arrangement may yield enrichment. Similarly, a fragment containing several nucleosomes can be recovered because one nucleosome bears the targeted histone modification; the experiment does not automatically assign that modification to every nucleosome in the fragment.\n\nThe spatial resolution is also distinct from the sequencing read length. If a recovered fragment is 250 base pairs long, sequencing its end does not locate the antibody-bound protein to a single nucleotide. Standard ChIP-seq commonly localizes enrichment to intervals spanning tens to hundreds of base pairs, depending on fragment length, target properties, sequencing design, and analysis. Specialized methods can narrow these intervals, but a narrow peak still represents a population-level inference rather than a microscopic image of contact.\n\nChIP usually averages over many cells, their chromosome copies, and the collection interval. A signal may arise from strong occupancy in a minority of cells or weaker occupancy across most cells. Likewise, overlapping maps from separate immunoprecipitations do not demonstrate that two proteins occupy the same DNA molecule simultaneously. These distinctions are especially important when studying heterogeneous tissues, dynamic signaling responses, or mutually exclusive chromatin states. ChIP is therefore most precisely described as a method for mapping recoverable chromatin associations under specified experimental conditions."
    },
    {
      "heading": "Chromatin preservation and fragmentation",
      "text": "Chromatin preparation determines which interactions survive and which genomic regions can enter the assay. Two broad strategies are used: crosslinked ChIP and native ChIP. Crosslinked ChIP usually fixes cells before disruption, whereas native ChIP isolates chromatin without covalently stabilizing its interactions. Neither approach is universally superior; their suitability depends on the stability and molecular context of the target.\n\nFormaldehyde is widely used because it generates short-range crosslinks involving reactive groups in proteins and nucleic acids. A frequently used starting condition is approximately 1% formaldehyde for about 10 minutes, but appropriate exposure varies substantially with cell type, tissue, and target. Excessive fixation can reduce solubility, mask an epitope, and impair fragmentation or DNA recovery. Insufficient fixation can allow transient associations to disappear during extraction. Some protocols use additional protein–protein crosslinkers before formaldehyde to improve recovery of indirectly associated complexes, at the cost of changing the molecular neighborhood retained by the assay.\n\nAfter fixation and quenching, cells or nuclei are disrupted and chromatin is fragmented. Sonication uses acoustic energy to shear chromatin, often producing DNA fragments in the approximate range of 100–500 base pairs for conventional ChIP-seq. The resulting distribution depends on instrument geometry, sample volume, fixation, and chromatin composition. Fragment size is generally assessed after reversing crosslinks in an aliquot, because intact crosslinked complexes do not behave like purified DNA during gel electrophoresis or related sizing procedures.\n\nEnzymatic fragmentation commonly uses micrococcal nuclease, which preferentially cleaves accessible DNA between nucleosomes. Limited digestion can generate mono- and oligonucleosomal material; more extensive digestion enriches fragments close to the nucleosomal DNA length. This is especially useful for native histone ChIP. However, nuclease cleavage has sequence preferences, and nucleosomes differ in their sensitivity to digestion. Overdigestion can therefore alter the representation of particular genomic regions or chromatin states.\n\nNative preparations avoid fixation-dependent epitope masking and crosslink reversal, but loosely bound proteins may dissociate or redistribute during extraction. They are most straightforward for stable nucleosomal targets, whereas many transcription factors require fixation for reliable recovery. Tissue samples introduce further complications, including uneven fixation penetration, difficult disruption, and mixtures of cell types. Isolation of selected cells or nuclei can improve biological specificity, although the isolation process itself may change the material available for analysis. Fragmentation and preservation are thus integral parts of the measurement, not merely preliminary handling steps."
    },
    {
      "heading": "Antibody capture, specificity, and experimental controls",
      "text": "The defining enrichment step is immunoprecipitation. An antibody recognizes the target protein or a particular modification, and the antibody–chromatin complex is retained on a solid support, commonly magnetic or agarose beads carrying protein A, protein G, or another antibody-binding reagent. Subsequent washes remove material that binds weakly or nonspecifically. The selected chromatin is then eluted, proteins are removed, and DNA is purified. In crosslinked assays, reversal of crosslinks is required before the DNA can be analyzed effectively.\n\nAntibody performance is often the largest determinant of assay success. An antibody that works in immunoblotting does not necessarily work in ChIP: denatured proteins expose different epitopes from proteins embedded in fixed chromatin. Histone-modification antibodies present additional challenges because nearby modifications may alter recognition, and a reagent may bind more than one methylation state or related peptide sequence. Lot-to-lot variation can also change enrichment profiles even when the nominal target remains the same.\n\nSpecificity can be evaluated through several complementary approaches. Genetic deletion or depletion of the target can reveal whether enrichment depends on its presence, although the perturbation may also change chromatin globally. Comparisons between independent antibodies recognizing different epitopes can strengthen confidence. Peptide-binding assays can characterize histone-antibody recognition, but isolated peptides do not fully reproduce nucleosomal structure. Endogenous epitope tagging provides an alternative capture strategy; however, a tag can affect protein function, abundance, localization, or accessibility and therefore requires biological validation.\n\nControls address different sources of background. An input sample, removed before immunoprecipitation, measures the representation of DNA in the starting chromatin. It helps account for fragmentation differences, copy-number variation, and sequencing or mapping biases. A nonspecific immunoglobulin G control assesses some forms of background associated with antibodies and beads. A no-antibody control measures bead-associated recovery. Neither control perfectly reproduces the behavior of the target-specific antibody, and a low-yield control can itself be difficult to analyze reproducibly.\n\nPositive and negative genomic regions are useful for assessing whether expected enrichment is present, but they should not substitute for genome-wide quality assessment. Biological replicates are essential because a technically clean library may still reflect an unrepresentative culture, tissue sample, or treatment response. Independent biological preparations capture variability that repeated sequencing of the same library cannot. Records of antibody identity and lot, fixation, fragmentation, starting material, and replicate design are therefore necessary for evaluating whether differences between experiments are biological or procedural."
    },
    {
      "heading": "DNA detection and quantitative readouts",
      "text": "After DNA recovery, the detection method determines the scale and character of the result. Conventional endpoint PCR can establish whether a selected region is represented, but it provides limited quantitative information. Quantitative PCR is widely used for targeted ChIP because it measures amplification during the exponential phase and can compare enrichment at known positive and negative regions. It is also useful for checking an immunoprecipitation before investing in genome-wide analysis.\n\nA common qPCR measure is percent input: the recovered amount at a locus expressed relative to the estimated amount of that locus in the starting chromatin. For equal amplification efficiencies close to 100%, it can be calculated as\n\n\\[\\%\\text{ input} = 100 \\times 2^{C_{t,\\mathrm{input,adjusted}}-C_{t,\\mathrm{IP}}},\\]\n\nwhere \\(C_t\\) is the amplification threshold cycle. If the input aliquot represents a fraction \\(f\\) of the material subjected to immunoprecipitation, its threshold cycle is adjusted by subtracting \\(\\log_2(1/f)\\), with further corrections for any differences in dilution and sampled volume. Percent input describes recovery, not the absolute fraction of chromatin occupied by the protein.\n\nChIP-chip detects recovered DNA through hybridization to microarrays. Arrays can cover promoters, selected genomic regions, or whole genomes, depending on their design. Although this approach enabled many early regulatory maps, its effective resolution depends on probe spacing and fragment length, while cross-hybridization complicates interpretation of related sequences. Modern studies more often use sequencing because it offers broader genomic coverage without requiring a separately designed set of hybridization probes.\n\nFor ChIP-seq, recovered DNA is converted into a sequencing library by adding adapters and, in many workflows, amplifying the resulting molecules. Paired-end sequencing reads both ends of each fragment and provides direct information about fragment length and genomic placement. Single-end sequencing can also support enrichment analysis, but fragment positions must be inferred more indirectly. Library amplification introduces additional biases, particularly when the amount of recovered DNA is small and many sequencing reads descend from relatively few original molecules.\n\nSequencing depth must match the target and question. A sharply localized transcription factor and a broad histone modification have different sampling requirements, and a complex mammalian genome generally demands more reads than a small microbial genome. Increasing sequencing cannot rescue an antibody that failed to enrich its target or a library with very low molecular complexity. Useful quality measures include mapping rate, the fraction of duplicated reads, fragment-length patterns, enrichment at expected regions, and the fraction of reads within called enriched intervals. These metrics require target-specific interpretation rather than a single universal pass threshold."
    },
    {
      "heading": "Computational analysis and comparison between samples",
      "text": "ChIP-seq analysis begins with assessing sequence quality and aligning reads to an appropriate reference genome. Reads that map ambiguously require particular care, especially in repetitive regions. Excluding all such reads simplifies analysis but creates systematic blind spots in centromeres, transposable elements, and other repeated sequences. Reference quality, sequence variation, and chromosome copy number can also affect apparent enrichment independently of protein association.\n\nAfter alignment, analytical choices include handling duplicate fragments, removing technical artifacts, estimating fragment distributions, and excluding problematic genomic intervals. Identical fragments may represent PCR amplification, but at strongly enriched sites they may also arise from independent molecules. Unique molecular identifiers can help distinguish these cases when incorporated into library preparation. Some genomic regions repeatedly produce unusually high signal across unrelated assays; treating such regions cautiously reduces false interpretation, although indiscriminate exclusion can also remove biologically relevant repetitive chromatin.\n\nPeak calling identifies intervals whose read density exceeds an estimated background. Narrow-peak algorithms are often suited to sequence-specific transcription factors, whereas broad-domain methods are more appropriate for marks such as histone H3 lysine 27 trimethylation, abbreviated H3K27me3. Input DNA can inform the local background model. Statistical significance depends on sequencing depth and the assumed model, so a small probability value does not establish a large biological effect. Likewise, peak boundaries are analytical estimates rather than physical borders of protein occupancy.\n\nReproducibility is assessed by comparing independent experiments. For sharply localized signals, irreproducible discovery rate analysis evaluates consistency in the ranking of enriched sites across replicates. Broad chromatin domains often require other measures, such as correlations across genomic windows or overlap between domains. The fraction of reads in peaks is informative but depends on how peaks were called, and it is not directly comparable across every target. A diffuse but genuine chromatin signal can have a lower value than a sharply concentrated transcription-factor signal.\n\nBetween-sample comparison introduces a fundamental normalization problem. Scaling every library to the same total number of reads effectively assumes that much of the genome is unchanged, or that increases and decreases approximately balance. This can conceal a global loss of a histone modification. Spike-in normalization introduces an external reference, often chromatin or cells from another species, to provide an additional scale. Its validity depends on consistent reference addition and recovery; an antibody must also recognize the relevant reference target when the reference is intended to pass through immunoprecipitation. Differential enrichment is therefore most informative when biological replication, background correction, normalization assumptions, and effect sizes are considered together."
    },
    {
      "heading": "Biological applications and functional interpretation",
      "text": "A major application of ChIP is the mapping of transcriptional regulation. ChIP-seq can identify genomic regions associated with a transcription factor and reveal whether those regions preferentially contain a particular DNA sequence motif. It also shows that many regulatory proteins bind far from annotated promoters. Such distal sites may function as enhancers, but assigning an enhancer to its target gene requires additional evidence because the nearest gene is not necessarily the regulated one.\n\nMaps of histone modifications provide another major use. Histone H3 lysine 4 trimethylation, or H3K4me3, is commonly enriched near active promoters. H3K36me3 is associated with transcribed gene bodies, while H3K27me3 frequently marks Polycomb-repressed regions and H3K9me3 is associated with many forms of constitutive heterochromatin. H3K27 acetylation is often used, together with other information, to distinguish active regulatory elements from related inactive states. These are context-dependent associations rather than a universal code in which each modification has one fixed meaning.\n\nCombinations of ChIP profiles can be used to infer chromatin states. For example, promoter-associated and enhancer-associated patterns can help annotate regulatory regions in different cell types. Apparent overlap between H3K4me3 and H3K27me3 has been used to describe bivalent chromatin, notably at some developmental genes in pluripotent cells. Separate bulk ChIP experiments, however, cannot determine whether both marks occur in the same cell, on the same chromosome copy, or within the same nucleosome.\n\nChIP also investigates processes beyond transcriptional control. Mapping components of DNA replication and DNA repair can reveal their recruitment to origins or damaged regions. ChIP of cohesin, CTCF, and related proteins contributes to studies of chromosome organization, although occupancy maps alone do not measure physical contacts between distant loci. Antibodies against centromeric histone variants help characterize specialized chromatin, while time-course experiments can track recruitment and release during signaling, differentiation, or the cell cycle.\n\nFunctional interpretation generally requires integration with other assays. RNA sequencing measures changes in transcript abundance, accessibility assays identify regions exposed to enzymatic probing, and genome editing can test whether a candidate regulatory sequence is necessary for a response. A transcription factor may bind a site without measurably regulating nearby transcription under the conditions examined. Conversely, altering a factor can change gene expression indirectly through regulatory cascades. The strongest mechanistic accounts distinguish association, temporal order, regulatory necessity, and direct molecular action instead of treating a ChIP peak as sufficient evidence for all four."
    },
    {
      "heading": "Resolution-enhancing methods and alternative chromatin profiling",
      "text": "Several methods extend ChIP by modifying how protein-associated DNA is processed. ChIP-exo, introduced by Rhee and Pugh in 2011, uses exonuclease digestion to trim immunoprecipitated DNA toward barriers created by crosslinked protein complexes. Sequencing the resulting boundaries can localize associations more precisely than conventional fragment-based ChIP-seq. ChIP-nexus, introduced in 2015, further refined exonuclease-based library preparation and molecular counting. These approaches improve positional information, but their boundaries still depend on crosslinking chemistry and complex structure.\n\nSequential ChIP, often called re-ChIP, subjects material recovered in one immunoprecipitation to a second capture with another antibody. Enrichment after both steps can support the presence of two targets on the same recovered chromatin fragment. It does not necessarily show that they directly contact one another or occupy one nucleosome, especially when fragments contain several nucleosomes. Material loss and incomplete elution can make the method demanding, while carryover and antibody compatibility complicate interpretation.\n\nOther chromatin-profiling methods replace the extraction and immunoprecipitation workflow with targeted enzymatic reactions inside permeabilized cells or nuclei. CUT&RUN, described by Skene and Henikoff in 2017, uses an antibody-directed nuclease to cleave DNA near the selected protein. Released fragments are then recovered for sequencing. Low nonspecific background can permit useful profiles from smaller samples than many conventional ChIP protocols, although performance remains dependent on the target, antibody, and cleavage conditions.\n\nCUT&Tag, introduced by Kaya-Okur and colleagues in 2019, uses an antibody-directed transposase complex to insert sequencing adapters near the target. This couples localization to library generation and can reduce handling losses. CUT&RUN and CUT&Tag are frequently discussed alongside ChIP because they address similar biological questions, but they are not simply interchangeable implementations of immunoprecipitation. Their enzymatic access requirements, backgrounds, fragment distributions, and sensitivity to chromatin accessibility differ from those of conventional ChIP-seq.\n\nLow-input and single-cell approaches have expanded the range of samples that can be investigated. Single-cell ChIP-seq was demonstrated by Rotem and colleagues in 2015, and later methods have improved multiplexing and sensitivity. Such experiments address heterogeneity concealed by bulk averages, but individual-cell profiles are usually sparse: failure to observe a fragment does not establish absence of the target at that locus. Computational aggregation across related cells can recover patterns, while introducing assumptions about how cells should be grouped. Higher positional resolution, lower input requirements, and single-cell measurement therefore solve different experimental problems rather than forming a single scale of method quality."
    },
    {
      "heading": "Technical limitations and unresolved interpretive problems",
      "text": "A persistent difficulty is separating biological occupancy from biochemical recoverability. Changes in chromatin compaction, nucleosome density, protein abundance, or epitope exposure can alter ChIP yield without a corresponding change in DNA-binding preference. Histone-modification ChIP is particularly sensitive to the distinction between modification abundance and the number of nucleosomes present. A region may lose modification signal because nucleosomes are removed, because the modification is erased, or because the antibody recognizes the remaining chromatin differently.\n\nAbsolute occupancy is generally not determined by standard ChIP. Crosslink formation is not equally efficient for every protein–DNA geometry, and immunoprecipitation rarely captures all target-bearing fragments. A weak signal may reflect low occupancy, brief residence time, poor crosslinking, inaccessible epitopes, or inefficient recovery. Time-resolved crosslinking approaches can investigate aspects of binding kinetics, but they require explicit models of fixation and association rather than a simple conversion of read counts into residence times.\n\nHighly active genomic regions can produce enrichment in experiments targeting unrelated proteins. Such “hyper-ChIPable” regions have been documented particularly clearly in yeast and illustrate how transcriptional activity, chromatin accessibility, and nonspecific recovery can combine to create misleading peaks. Appropriate controls and independent validation reduce this problem, but no single background correction removes every artifact. Conversely, heterochromatin and repetitive DNA can be underrepresented because of poor solubilization or ambiguous mapping, creating apparent absences that are technical rather than biological.\n\nCell mixtures create another layer of ambiguity. A tissue-level difference may reflect altered proportions of cell types rather than a chromatin change within a fixed cell population. Allele-specific analysis can reveal differences between chromosome copies when informative sequence variants are present, but mapping bias toward the reference allele must be addressed. Copy-number changes also affect the quantity of recoverable DNA, which is particularly relevant in genetically heterogeneous samples. Input controls help characterize these effects but do not resolve every source of cellular variation.\n\nComparability across laboratories remains limited by differences in antibodies, fixation, fragmentation, library construction, reference genomes, and analytical thresholds. Public datasets are valuable only when their experimental context is considered, especially when combining targets with different enrichment patterns or samples prepared by different methods. Reporting raw sequencing data, processed signal tracks, controls, replicate relationships, and detailed metadata permits alternative analyses and more meaningful reuse. For a particular locus, the remaining mechanistic question is often not whether enrichment exists, but which molecular interaction produced it and whether that interaction changes chromosome function."
    }
  ],
  "links": [
    "dna",
    "protein",
    "antibody",
    "chromatin",
    "transcription-factor",
    "histone",
    "genome",
    "gene-expression",
    "epigenetics",
    "dna-sequencing",
    "rna-polymerase",
    "polymerase-chain-reaction",
    "promoter-biology",
    "chip-seq",
    "eukaryote",
    "nucleosome",
    "cell",
    "epitope",
    "gel-electrophoresis",
    "immunoglobulin-g",
    "quantitative-pcr",
    "enhancer-biology",
    "gene",
    "dna-replication",
    "dna-repair",
    "cell-cycle",
    "rna-sequencing",
    "genome-editing",
    "allele"
  ],
  "sources": [],
  "license": "https://creativecommons.org/licenses/by/4.0/"
}